Found: 109
Select item for more details and to access through your institution.
Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 5, p. 789, doi. 10.1007/s11523-024-01075-8
- By:
- Publication type:
- Article
Fasting protects against the side effects of irinotecan treatment but does not affect anti-tumour activity in mice.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 2, p. 163, doi. 10.1007/s40261-021-01114-6
- By:
- Publication type:
- Article
Effects of smoking and body mass index on the exposure of fentanyl in patients with cancer.
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0198289
- By:
- Publication type:
- Article
Mechanism-based models for topotecan-induced neutropenia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 567, doi. 10.1016/j.clpt.2004.08.008
- By:
- Publication type:
- Article
Clinical pharmacokinetics of irinotecan and its metabolites in relation with diarrhea<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 72, n. 3, p. 265, doi. 10.1067/mcp.2002.126741
- By:
- Publication type:
- Article
Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects?
- Published in:
- Drugs, 2024, v. 84, n. 4, p. 385, doi. 10.1007/s40265-024-02010-x
- By:
- Publication type:
- Article
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies.
- Published in:
- Drugs, 2023, v. 83, n. 2, p. 159, doi. 10.1007/s40265-022-01828-7
- By:
- Publication type:
- Article
Prediction of irinotecan pharmacokinetics by use of cytochrome P450 3A4 phenotyping probes.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Improving the tolerability of osimertinib by identifying its toxic limit.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221103212
- By:
- Publication type:
- Article
Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221081075
- By:
- Publication type:
- Article
The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors.
- Published in:
- Pharmaceutical Research, 2020, v. 37, n. 1, p. 1, doi. 10.1007/s11095-019-2746-9
- By:
- Publication type:
- Article
Does Older Age Lead to Higher Risk for Neutropenia in Patients Treated with Paclitaxel?
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 12, p. N.PAG, doi. 10.1007/s11095-019-2697-1
- By:
- Publication type:
- Article
Impact of Older Age on the Exposure of Paclitaxel: a Population Pharmacokinetic Study.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 2, p. 1, doi. 10.1007/s11095-018-2563-6
- By:
- Publication type:
- Article
Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The added value of H<sub>2</sub> antagonists in premedication regimens during paclitaxel treatment.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Androgen receptor signalling impairs docetaxel efficacy in castration-resistant prostate cancer.
- Published in:
- British Journal of Cancer, 2020, v. 123, n. 12, p. 1715, doi. 10.1038/s41416-020-01105-y
- By:
- Publication type:
- Article
Androgen receptor signalling impairs docetaxel efficacy in castration-resistant prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Intraperitoneal chemotherapy for peritoneal metastases of gastric origin: a systematic review and meta-analysis.
- Published in:
- British Journal of Surgery, 2024, v. 111, n. 5, p. 1, doi. 10.1093/bjs/znae116
- By:
- Publication type:
- Article
Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastases.
- Published in:
- British Journal of Surgery, 2023, v. 110, n. 11, p. 1502, doi. 10.1093/bjs/znad228
- By:
- Publication type:
- Article
Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trial.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 195, n. 1, p. 65, doi. 10.1007/s10549-022-06643-y
- By:
- Publication type:
- Article
Correction to: Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 1, p. 107, doi. 10.1007/s10549-020-05829-6
- By:
- Publication type:
- Article
Tamoxifen-induced fatty liver disease in a Caucasian patient.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 243, doi. 10.1007/s10549-018-4817-8
- By:
- Publication type:
- Article
Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 9, p. 1309, doi. 10.1007/s00228-019-02704-2
- By:
- Publication type:
- Article
Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of Tamoxifen.
- Published in:
- Frontiers in Pharmacology, 2020, p. 1, doi. 10.3389/fphar.2020.00283
- By:
- Publication type:
- Article
CYP3A4<sup>∗</sup>22 Genotyping in Clinical Practice: Ready for Implementation?
- Published in:
- Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.711943
- By:
- Publication type:
- Article
Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD Variants.
- Published in:
- Genes, 2018, v. 9, n. 12, p. 585, doi. 10.3390/genes9120585
- By:
- Publication type:
- Article
mFast‐SeqS‐based aneuploidy score in circulating cell‐free DNA is a prognostic biomarker in prostate cancer.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 9, p. 1898, doi. 10.1002/1878-0261.13449
- By:
- Publication type:
- Article
AR splice variants in circulating tumor cells of patients with castration‐resistant prostate cancer: relation with outcome to cabazitaxel.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 8, p. 1795, doi. 10.1002/1878-0261.12529
- By:
- Publication type:
- Article
Flat-Fixed Dosing Versus Body Surface Area-Based Dosing of Anticancer Drugs in Adults: Does It Make a Difference?
- Published in:
- Oncologist, 2007, v. 12, n. 8, p. 913, doi. 10.1634/theoncologist.12-8-913
- By:
- Publication type:
- Article
Medicinal Cannabis Does Not Influence the Clinical Pharmacokinetics of Irinotecan and Docetaxel.
- Published in:
- Oncologist, 2007, v. 12, n. 3, p. 291, doi. 10.1634/theoncologist.12-3-291
- By:
- Publication type:
- Article
Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC).
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1136221
- By:
- Publication type:
- Article
Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 7, p. 1045, doi. 10.1007/s40262-024-01399-8
- By:
- Publication type:
- Article
The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 7, p. 1037, doi. 10.1007/s40262-024-01390-3
- By:
- Publication type:
- Article
Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 11, p. 1589, doi. 10.1007/s40262-023-01279-7
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 10, p. 1333, doi. 10.1007/s40262-023-01293-9
- By:
- Publication type:
- Article
CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 8, p. 1129, doi. 10.1007/s40262-023-01260-4
- By:
- Publication type:
- Article
Influence of Darolutamide on Cabazitaxel Systemic Exposure.
- Published in:
- 2022
- By:
- Publication type:
- letter
Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing: Feasible in Patients with Hormone-Sensitive Breast Cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Predictors for doxorubicin-induced hematological toxicity and its association with outcome in advanced soft tissue sarcoma patients; a retrospective analysis of the EORTC-soft tissue and bone sarcoma group database.
- Published in:
- Acta Oncologica, 2018, v. 57, n. 8, p. 1117, doi. 10.1080/0284186X.2018.1449248
- By:
- Publication type:
- Article
Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0048372
- By:
- Publication type:
- Article
Prophylaxis of Irinotecan-Induced Diarrhea with Neomycin and Potential Role for UGT1A1*28 Genotype Screening: A Double-Blind, Randomized, Placebo-Controlled Study.
- Published in:
- Oncologist, 2006, v. 11, n. 8, p. 944, doi. 10.1634/theoncologist.11-8-944
- By:
- Publication type:
- Article
Individualized Dosing Patterns in the Treatment of Older Patients with Gastrointestinal Stromal Tumors: Results of a Registry-Based Observational National Cohort Study Including 871 Patients.
- Published in:
- Drugs & Aging, 2024, v. 41, n. 2, p. 165, doi. 10.1007/s40266-023-01084-8
- By:
- Publication type:
- Article
Clinically relevant drug interactions with multikinase inhibitors: a review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835918818347
- By:
- Publication type:
- Article
Clinically relevant drug interactions with multikinase inhibitors: a review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835918818347
- By:
- Publication type:
- Article
Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 4, p. 1, doi. 10.1007/s00018-022-04226-0
- By:
- Publication type:
- Article
Sunitinib-induced hypothyroidism is due to induction of type 3 deiodinase activity and thyroidal capillary regression.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Landscape of driver gene events, biomarkers, and druggable targets identified by whole-genome sequencing of glioblastomas.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdab177
- By:
- Publication type:
- Article